{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:16:08Z","timestamp":1788869768953,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20220336"],"award-info":[{"award-number":["20220336"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02382-z","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:04:29Z","timestamp":1782230669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A combined model integrating adiponectin and anthropometric indices for the identification of insulin resistance in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiuping","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiliu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3206-3976","authenticated-orcid":false,"given":"Guangya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2382_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","volume":"41","author":"BB Duncan","year":"2025","unstructured":"Duncan BB, Magliano DJ, Boyko EJ. IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050. Nephrol Dialysis Transplantation. 2025;41:7\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfaf177.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"2382_CR2","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.2337\/dc26-S008","volume":"49 Supplement1","author":"M Bajaj","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes\u20132026. Diabetes Care. 2026;49 Supplement1:S166\u201382. https:\/\/doi.org\/10.2337\/dc26-S008.","journal-title":"Diabetes Care"},{"key":"2382_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2382_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ijms26031094","volume":"26","author":"E M\u0142ynarska","year":"2025","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N, J\u0119draszak W, Majchrowicz G, Prusinowski F, et al. Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. IJMS. 2025;26:1094. https:\/\/doi.org\/10.3390\/ijms26031094.","journal-title":"IJMS"},{"key":"2382_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/nu16071015","volume":"16","author":"S Dhokte","year":"2024","unstructured":"Dhokte S, Czaja K. Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes. Nutrients. 2024;16:1015. https:\/\/doi.org\/10.3390\/nu16071015.","journal-title":"Nutrients"},{"key":"2382_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139. https:\/\/doi.org\/10.1007\/BF00280883.","journal-title":"Diabetologia"},{"key":"2382_CR7","doi-asserted-by":"publisher","unstructured":"Moriyama K. Mini-review on insulin resistance assessment: advances in surrogate indices and clinical applications. World J Clin Cases. 2025;13. https:\/\/doi.org\/10.12998\/wjcc.v13.i29.108380.","DOI":"10.12998\/wjcc.v13.i29.108380"},{"key":"2382_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/br.2024.1883","volume":"22","author":"A Al\u2013Dwairi","year":"2024","unstructured":"Al\u2013Dwairi A, Alfaqih M, Saadeh R, Al\u2013Shboul O, Alqudah M, Khanfar M, et al. Lack of glycemic control in type two diabetes mellitus patients is associated with reduced serum epidermal growth factor level and increased insulin resistance. Biomed Rep. 2024;22:5. https:\/\/doi.org\/10.3892\/br.2024.1883.","journal-title":"Biomed Rep"},{"key":"2382_CR9","doi-asserted-by":"publisher","first-page":"873699","DOI":"10.3389\/fendo.2022.873699","volume":"13","author":"Y Ren","year":"2022","unstructured":"Ren Y, Zhao H, Yin C, Lan X, Wu L, Du X, et al. Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation. Front Endocrinol. 2022;13:873699. https:\/\/doi.org\/10.3389\/fendo.2022.873699.","journal-title":"Front Endocrinol"},{"key":"2382_CR10","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.jpha.2023.12.003","volume":"14","author":"Y Han","year":"2024","unstructured":"Han Y, Sun Q, Chen W, Gao Y, Ye J, Chen Y, et al. New advances of adiponectin in regulating obesity and related metabolic syndromes. J Pharm Anal. 2024;14:100913. https:\/\/doi.org\/10.1016\/j.jpha.2023.12.003.","journal-title":"J Pharm Anal"},{"key":"2382_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/ijerph21060757","volume":"21","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li D, Vermund SH. Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity. IJERPH. 2024;21:757. https:\/\/doi.org\/10.3390\/ijerph21060757.","journal-title":"IJERPH"},{"key":"2382_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.36408\/mhjcm.v11i3.1156","volume":"11","author":"RA Afriansyah","year":"2024","unstructured":"Afriansyah RA, Seno KHNH, Chandra A, Ngestiningsih D. Association between Waist-Hip Ratio and Body Fat Composition, and Metabolic Syndrome: A Study at RSUP dr. Kariadi. Med Hospitalia J Clin Med. 2024;11:318\u201324. https:\/\/doi.org\/10.36408\/mhjcm.v11i3.1156.","journal-title":"Med Hospitalia J Clin Med"},{"key":"2382_CR13","doi-asserted-by":"publisher","first-page":"e2452185","DOI":"10.1001\/jamanetworkopen.2024.52185","volume":"7","author":"A Jayedi","year":"2024","unstructured":"Jayedi A, Soltani S, Emadi A, Zargar M-S, Najafi A. Aerobic Exercise and Weight Loss in Adults: A Systematic Review and Dose-Response Meta-Analysis. JAMA Netw Open. 2024;7:e2452185. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.52185.","journal-title":"JAMA Netw Open"},{"key":"2382_CR14","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 5. Facilitating Positive health behaviors and well-being to improve health outcomes: standards of care in diabetes\u20142026. Diabetes Care. 2026;49 Supplement_1:S89\u2013131. https:\/\/doi.org\/10.2337\/dc26-S005","DOI":"10.2337\/dc26-S005"},{"key":"2382_CR15","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1111\/obr.70031","volume":"27","author":"M Khalafi","year":"2026","unstructured":"Khalafi M, Fatolahi S, Symonds ME, Dinizadeh F, Rosenkranz SK, Batrakoulis A. Comparative Efficacy of Exercise Type on Visceral Adipose Tissue in Patients With Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review With Pairwise and Network Meta-Analyses. Obes Rev. 2026;27:e70031. https:\/\/doi.org\/10.1111\/obr.70031.","journal-title":"Obes Rev"},{"key":"2382_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.cmet.2023.12.025","volume":"36","author":"J Noone","year":"2024","unstructured":"Noone J, Mucinski JM, DeLany JP, Sparks LM, Goodpaster BH. Understanding the variation in exercise responses to guide personalized physical activity prescriptions. Cell Metabol. 2024;36:702\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2023.12.025.","journal-title":"Cell Metabol"},{"key":"2382_CR17","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc26-S002","volume":"49 Supplement1","author":"M Bajaj","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49 Supplement1:S27\u201349. https:\/\/doi.org\/10.2337\/dc26-S002.","journal-title":"Diabetes Care"},{"key":"2382_CR18","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"B Zhou","year":"2024","unstructured":"Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404:2077\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(24)02317-1.","journal-title":"Lancet"},{"key":"2382_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.53469\/jcmp.2026.08(01).38","volume":"8","author":"X Li","year":"2026","unstructured":"Li X, Wang H, Tian S. The Correlation, Prevention, and Treatment of Obesity and Type 2 Diabetes. JCMP. 2026;8:220\u20134. https:\/\/doi.org\/10.53469\/jcmp.2026.08(01).38.","journal-title":"JCMP"},{"key":"2382_CR20","doi-asserted-by":"publisher","first-page":"bvac059","DOI":"10.1210\/jendso\/bvac059","volume":"6","author":"M Mongraw-Chaffin","year":"2022","unstructured":"Mongraw-Chaffin M, Saldana S, Carnethon MR, Chen H, Effoe V, Golden SH, et al. Determinants of Metabolic Syndrome and Type 2 Diabetes in the Absence of Obesity: The Jackson Heart Study. J Endocr Soc. 2022;6:bvac059. https:\/\/doi.org\/10.1210\/jendso\/bvac059.","journal-title":"J Endocr Soc"},{"key":"2382_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11033-026-11509-3","volume":"53","author":"YN Choo","year":"2026","unstructured":"Choo YN, Ravi RN, Subramaniyan V. Insulin resistance induced by obesity: Mechanisms, metabolic implications and therapeutic approaches. Mol Biol Rep. 2026;53:357. https:\/\/doi.org\/10.1007\/s11033-026-11509-3.","journal-title":"Mol Biol Rep"},{"key":"2382_CR22","first-page":"289","volume":"38","author":"Chinese Society of Endocrinology","year":"2022","unstructured":"Chinese Society of Endocrinology. Chinese guideline for the prevention and treatment of type 2 diabetes mellitus (2022 edition). Chin J Endocrinol Metab. 2022;38:289\u2013356.","journal-title":"Chin J Endocrinol Metab"},{"key":"2382_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, Den Hartigh LJ. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front Cardiovasc Med. 2020;7:22. https:\/\/doi.org\/10.3389\/fcvm.2020.00022.","journal-title":"Front Cardiovasc Med"},{"key":"2382_CR24","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","volume":"10","author":"F Zatterale","year":"2020","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020;10:1607. https:\/\/doi.org\/10.3389\/fphys.2019.01607.","journal-title":"Front Physiol"},{"key":"2382_CR25","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T Kawai","year":"2021","unstructured":"Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiology-Cell Physiol. 2021;320:C375\u201391. https:\/\/doi.org\/10.1152\/ajpcell.00379.2020.","journal-title":"Am J Physiology-Cell Physiol"},{"key":"2382_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13410-023-01249-6","volume":"44","author":"AN Andevari","year":"2024","unstructured":"Andevari AN, Moein S, Qujeq D, Moazezi Z, Tilaki KH. The effect of atorvastatin on the concentrations of methylglyoxal, glyoxalase 1, and aldo\u2013keto reductase family 1 member B10 in patients with type 2 diabetes mellitus and prediabetes. Int J Diabetes Dev Ctries. 2024;44:400\u20138. https:\/\/doi.org\/10.1007\/s13410-023-01249-6.","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2382_CR27","doi-asserted-by":"publisher","unstructured":"Andevari AN, Firoozjaee AH, Meftah N, Asciabari HA, Bahri F, Shahandashti NE, et al. The effects of atorvastatin consumption on blood levels of sortilin, glycemic, and lipid indices in type 2 diabetic patients: a randomized clinical trial. Int J Diabetes Dev Ctries. 2025;1\u20138. https:\/\/doi.org\/10.1007\/s13410-025-01557-z.","DOI":"10.1007\/s13410-025-01557-z"},{"key":"2382_CR28","doi-asserted-by":"publisher","DOI":"10.18502\/aptj.v5i3.20517","author":"AN Andevari","year":"2025","unstructured":"Andevari AN, Qujeq D. Anti-inflammatory Mechanisms Beyond Cholesterol-Lowering Capabilities of Statins: Evidence from in vitro and in vivo Studies. APTJ. 2025. https:\/\/doi.org\/10.18502\/aptj.v5i3.20517.","journal-title":"APTJ"},{"key":"2382_CR29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, H\u00e4ring H-U. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12:721\u201337. https:\/\/doi.org\/10.1038\/nrneph.2016.145.","journal-title":"Nat Rev Nephrol"},{"key":"2382_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cca.2018.06.029","volume":"485","author":"K Nakajima","year":"2018","unstructured":"Nakajima K, Tokita Y, Tanaka A, Hypothesis. Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity. Clin Chim Acta. 2018;485:126\u201332. https:\/\/doi.org\/10.1016\/j.cca.2018.06.029.","journal-title":"Clin Chim Acta"},{"key":"2382_CR31","doi-asserted-by":"publisher","first-page":"e240401","DOI":"10.1530\/EC-24-0401","volume":"14","author":"J Yang","year":"2024","unstructured":"Yang J, Lin M, Tian X, Li C, Wu H, Deng L, et al. Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome. Endocr Connections. 2024;14:e240401. https:\/\/doi.org\/10.1530\/EC-24-0401.","journal-title":"Endocr Connections"},{"key":"2382_CR32","first-page":"3","volume":"24","author":"S Stojanovic","year":"2020","unstructured":"Stojanovic S, Deljanin-Ilic M, Ilic S, Stefanovic M, Petrovic D, Petrovic V, et al. Adiponectin resistance parameter as a marker for high normal blood pressure and hypertension in patients with metabolic syndrome. Hippokratia. 2020;24:3\u20137.","journal-title":"Hippokratia"},{"key":"2382_CR33","volume-title":"StatPearls. Treasure Island","author":"AM Freeman","year":"2026","unstructured":"Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. StatPearls. Treasure Island. (FL): StatPearls Publishing; 2026."},{"key":"2382_CR34","doi-asserted-by":"publisher","first-page":"18472","DOI":"10.1038\/s41598-024-69338-y","volume":"14","author":"C Ma","year":"2024","unstructured":"Ma C, Cheng B, Zhou L, Cai S, Qin B, Sun J, et al. Association between insulin resistance and vascular damage in an adult population in China: a cross-sectional study. Sci Rep. 2024;14:18472. https:\/\/doi.org\/10.1038\/s41598-024-69338-y.","journal-title":"Sci Rep"},{"key":"2382_CR35","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288\u201395. https:\/\/doi.org\/10.1038\/nm788.","journal-title":"Nat Med"},{"key":"2382_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T. Adiponectin and Adiponectin Receptors. Endocr Rev. 2005;26:439\u201351. https:\/\/doi.org\/10.1210\/er.2005-0005.","journal-title":"Endocr Rev"},{"key":"2382_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473\u201381. https:\/\/doi.org\/10.1172\/JCI10842.","journal-title":"J Clin Invest"},{"key":"2382_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41577-024-01103-8","volume":"25","author":"H Tilg","year":"2025","unstructured":"Tilg H, Ianiro G, Gasbarrini A, Adolph TE. Adipokines: masterminds of metabolic inflammation. Nat Rev Immunol. 2025;25:250\u201365. https:\/\/doi.org\/10.1038\/s41577-024-01103-8.","journal-title":"Nat Rev Immunol"},{"key":"2382_CR39","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/biomedicines13071770","volume":"13","author":"J Rausch","year":"2025","unstructured":"Rausch J, Horne KE, Marquez L. The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus. Biomedicines. 2025;13:1770. https:\/\/doi.org\/10.3390\/biomedicines13071770.","journal-title":"Biomedicines"},{"key":"2382_CR40","doi-asserted-by":"publisher","first-page":"1327716","DOI":"10.3389\/fendo.2024.1327716","volume":"15","author":"L He","year":"2024","unstructured":"He L, Xuan W, Liu D, Zhong J, Luo H, Cui H, et al. The role of adiponectin in the association between abdominal obesity and type 2 diabetes: a mediation analysis among 232,438 Chinese participants. Front Endocrinol. 2024;15:1327716. https:\/\/doi.org\/10.3389\/fendo.2024.1327716.","journal-title":"Front Endocrinol"},{"key":"2382_CR41","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.tem.2024.05.004","volume":"35","author":"Y Li","year":"2024","unstructured":"Li Y, Onodera T, Scherer PE, Adiponectin. Trends Endocrinol Metabolism. 2024;35:674\u20135. https:\/\/doi.org\/10.1016\/j.tem.2024.05.004.","journal-title":"Trends Endocrinol Metabolism"},{"key":"2382_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85\u201397. https:\/\/doi.org\/10.1038\/nri2921.","journal-title":"Nat Rev Immunol"},{"key":"2382_CR43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof A, Despr\u00e9s J-P. Pathophysiology of Human Visceral Obesity: An Update. Physiol Rev. 2013;93:359\u2013404. https:\/\/doi.org\/10.1152\/physrev.00033.2011.","journal-title":"Physiol Rev"},{"key":"2382_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747.","journal-title":"Radiology"},{"key":"2382_CR45","doi-asserted-by":"publisher","first-page":"1761342","DOI":"10.3389\/fendo.2025.1761342","volume":"16","author":"J Zhao","year":"2026","unstructured":"Zhao J, An X, Liu L, Meng J, Liu L, Mu Y. Construction and validation of a risk prediction model for metabolic syndrome: a cross-sectional study based on randomized sampling. Front Endocrinol. 2026;16:1761342. https:\/\/doi.org\/10.3389\/fendo.2025.1761342.","journal-title":"Front Endocrinol"},{"key":"2382_CR46","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.ijmedinf.2024.105480","volume":"188","author":"W Xiaoxue","year":"2024","unstructured":"Xiaoxue W, Zijun W, Shichen C, Mukun Y, Yi C, Linqing M, et al. Risk prediction model of metabolic syndrome in perimenopausal women based on machine learning. Int J Med Informatics. 2024;188:105480. https:\/\/doi.org\/10.1016\/j.ijmedinf.2024.105480.","journal-title":"Int J Med Informatics"},{"key":"2382_CR47","doi-asserted-by":"publisher","first-page":"e0339340","DOI":"10.1371\/journal.pone.0339340","volume":"20","author":"MA Zahid","year":"2025","unstructured":"Zahid MA, Abdelrahman A, Ra\u00efq H, Kerkadi A, Agouni A. Assessing the diagnostic accuracy of biochemical, anthropometric, and combined indices for metabolic syndrome prediction in a cohort from Qatar Biobank. PLoS ONE. 2025;20:e0339340. https:\/\/doi.org\/10.1371\/journal.pone.0339340.","journal-title":"PLoS ONE"},{"key":"2382_CR48","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/jcm14020448","volume":"14","author":"J Park","year":"2025","unstructured":"Park J, Byun Y, Kim S. Predictive Diagnostic Power of Anthropometric Indicators for Metabolic Syndrome: A Comparative Study in Korean Adults. JCM. 2025;14:448. https:\/\/doi.org\/10.3390\/jcm14020448.","journal-title":"JCM"},{"key":"2382_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1249\/MSS.0000000000002800","volume":"54","author":"JA Kanaley","year":"2022","unstructured":"Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, et al. Exercise\/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54:353\u201368. https:\/\/doi.org\/10.1249\/MSS.0000000000002800.","journal-title":"Med Sci Sports Exerc"},{"key":"2382_CR50","doi-asserted-by":"publisher","first-page":"109979","DOI":"10.1016\/j.diabres.2022.109979","volume":"190","author":"R Mateo-Gallego","year":"2022","unstructured":"Mateo-Gallego R, Madinaveitia-Nisarre L, Gin\u00e9-Gonzalez J, Mar\u00eda Bea A, Guerra-Torrecilla L, Baila-Rueda L, et al. The effects of high-intensity interval training on glucose metabolism, cardiorespiratory fitness and weight control in subjects with diabetes: Systematic review a meta-analysis. Diabetes Res Clin Pract. 2022;190:109979. https:\/\/doi.org\/10.1016\/j.diabres.2022.109979.","journal-title":"Diabetes Res Clin Pract"},{"key":"2382_CR51","doi-asserted-by":"publisher","first-page":"112941","DOI":"10.1016\/j.diabres.2025.112941","volume":"229","author":"J Wang","year":"2025","unstructured":"Wang J, Fan S, Wang J. Resistance training enhances metabolic and muscular health and reduces systemic inflammation in middle-aged and older adults with type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2025;229:112941. https:\/\/doi.org\/10.1016\/j.diabres.2025.112941.","journal-title":"Diabetes Res Clin Pract"},{"key":"2382_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13098-025-01811-8","volume":"17","author":"A Pourkoshki","year":"2025","unstructured":"Pourkoshki A, Monazzami A, Heydarpour F, Yon DK, Smith L, Rahmati M. Exercise training and inflammatory adipokines in patients with type 2 diabetes: a systematic review, meta-analysis, and meta-regression. Diabetol Metab Syndr. 2025;17:224. https:\/\/doi.org\/10.1186\/s13098-025-01811-8.","journal-title":"Diabetol Metab Syndr"},{"key":"2382_CR53","doi-asserted-by":"publisher","first-page":"e17525","DOI":"10.7717\/peerj.17525","volume":"12","author":"SB AL-Mhanna","year":"2024","unstructured":"AL-Mhanna SB, Batrakoulis A, Wan Ghazali WS, Mohamed M, Aldayel A, Alhussain MH, et al. Effects of combined aerobic and resistance training on glycemic control, blood pressure, inflammation, cardiorespiratory fitness and quality of life in patients with type 2 diabetes and overweight\/obesity: a systematic review and meta-analysis. PeerJ. 2024;12:e17525. https:\/\/doi.org\/10.7717\/peerj.17525.","journal-title":"PeerJ"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02382-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:02:40Z","timestamp":1788868960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02382-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02382-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Cangzhou Central Hospital, Hebei (Approval No. 2021-074-02 (z)). Written informed consent to participate was obtained from all participants before their inclusion in the study. All procedures were conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"261"}}